Starling Oncology, Inc. - Common Stock (STLN)

4.9900
-0.0400 (-0.80%)
NASDAQ· Last Trade: Aug 6th, 7:38 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close5.030
Open4.950
Bid5.800
Ask5.930
Day's Range4.850 - 5.045
52 Week Range4.850 - 5.290
Volume1,989,936
Market Cap-
PE Ratio (TTM)-
EPS (TTM)-
Dividend & YieldN/A (N/A)
1 Month Average Volume1,349,275

Chart

News & Press Releases

Starling Oncology Reports Second Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance
CERRITOS, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Starling Oncology, Inc. (NASDAQ: STLN) (“STLN” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its quarter ended June 30, 2026 and updated it's full-year 2026 guidance.
By Starling Oncology · Via GlobeNewswire · August 6, 2026